ENDRA Life Sciences, Inc. (NDRA) Francois Michelon, CEO

The pioneer of Thermo Acoustic EnhancedUltraSound (TAEUS®), aground-breaking technology which characterizes tissue similar to an MRI, but at1/50th the costand at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000ultrasound systems in use globally today. TAEUS® is initially focused on the measurementof fat in the liver as a means to assess and monitor steatotic liver disease(SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum thataffects over two billion people globally, and for which there are no practicaldiagnostic tools. Beyond the liver, ENDRA is exploring several other clinicalapplications of TAEUS®, includingvisualization of tissue temperature during energy-based surgical procedures.